Macitentan cuts morbidity, death in pulmonary arterial HTN
(HealthDay)—For patients with pulmonary arterial hypertension, the new dual endothelin-receptor antagonist macitentan is associated with reductions in morbidity and mortality, according to a study published in the Aug. ...
Aug 29, 2013
0
0